| Mobile technology identity and self-efficacy: Implications for the adoption of clinically supported mobile health apps A Balapour, I Reychav, R Sabherwal, J Azuri International Journal of Information Management 49, 58-68, 2019 | 248 | 2019 |
| Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer D Rodríguez-Martín, A Samà, C Pérez-López, A Català, ... PloS one 12 (2), e0171764, 2017 | 188 | 2017 |
| How reliable are self-assessments using mobile technology in healthcare? The effects of technology identity and self-efficacy I Reychav, R Beeri, A Balapour, DR Raban, R Sabherwal, J Azuri Computers in Human Behavior 91, 52-61, 2019 | 122 | 2019 |
| Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) N Danchin, W Almahmeed, K Al-Rasadi, J Azuri, A Berrah, CA Cuneo, ... European journal of preventive cardiology 25 (10), 1087-1094, 2018 | 118 | 2018 |
| Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements D Elstein, I Hadas-Halpern, Y Azuri, A Abrahamov, Y Bar-Ziv, A Zimran Journal of ultrasound in medicine 16 (3), 209-211, 1997 | 86 | 1997 |
| Reassuring the medical students’ disease–Health related anxiety among medical students J Azuri, N Ackshota, S Vinker Medical teacher 32 (7), e270-e275, 2010 | 78 | 2010 |
| Use of humour in primary care: different perceptions among patients and physicians M Granek-Catarivas, S Goldstein-Ferber, Y Azuri, S Vinker, E Kahan Postgraduate medical journal 81 (952), 126-130, 2005 | 53 | 2005 |
| Asymptomatic Gaucher disease implications for large-scale screening J AZURI, D ELSTEIN, A LAHAD, A ABRAHAMOV, I HADAS-HALPERN, ... Genetic Testing 2 (4), 297-299, 1998 | 51 | 1998 |
| Measurement issues in anthropometric measures of limb volume change in persons at risk for and living with lymphedema: a reliability study D Tidhar, JM Armer, D Deutscher, CR Shyu, J Azuri, R Madsen Journal of personalized medicine 5 (4), 341-353, 2015 | 48 | 2015 |
| Liver damage due to alendronate. A Halabe, BM Lifschitz, J Azuri The New England Journal of Medicine 343 (5), 365-366, 2000 | 48 | 2000 |
| The impact of residents’ training in Electronic Medical Record (EMR) use on their competence: Report of a pragmatic trial S Reis, D Sagi, O Eisenberg, Y Kuchnir, J Azuri, V Shalev, A Ziv Patient Education and Counseling 93 (3), 515-521, 2013 | 40 | 2013 |
| Outcomes of different protocols of pelvic floor physical therapy and anti‐cholinergics in women with wet over‐active bladder: A 4‐year follow‐up J Azuri, R Kafri, T Ziv‐Baran, K Stav Neurourology and urodynamics 36 (3), 755-758, 2017 | 33 | 2017 |
| Using tablets in medical consultations: Single loop and double loop learning processes I Reychav, R Kumi, R Sabherwal, J Azuri Computers in Human Behavior 61, 415-426, 2016 | 31 | 2016 |
| The ability of older adults to use customized online medical databases to improve their health-related knowledge O Freund, I Reychav, R McHaney, E Goland, J Azuri International Journal of Medical Informatics 102, 1-11, 2017 | 30 | 2017 |
| Identifying important health system factors that influence primary care practitioners’ referrals for cancer suspicion: a European cross-sectional survey M Harris, P Vedsted, M Esteva, P Murchie, I Aubin-Auger, J Azuri, ... BMJ open 8 (9), e022904, 2018 | 29 | 2018 |
| Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective N Siegelmann-Danieli, I Katzir, JV Landes, Y Segal, R Bachar, ... Breast cancer research and treatment 167, 257-262, 2018 | 28 | 2018 |
| Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study L Adler, S Gazit, Y Pinto, G Perez, M Mizrahi Reuveni, I Yehoshua, ... Scandinavian Journal of Primary Health Care 40 (3), 342-349, 2022 | 26 | 2022 |
| Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis J Azuri, A Hammerman, E Aboalhasan, B Sluckis, R Arbel Diabetes, Obesity and Metabolism 25 (4), 961-964, 2023 | 25 | 2023 |
| Guillain-Barré syndrome following serological evidence of hepatitis A in a child J Azuri, T Lerman-Sagie, A Mizrahi, Y Bujanover European journal of pediatrics 158 (4), 341, 1999 | 25 | 1999 |
| Assessment of the underestimation of childhood diarrhoeal disease burden in Israel T Ziv, AD Heymann, J Azuri, M Leshno, D Cohen Epidemiology & Infection 139 (9), 1379-1387, 2011 | 23 | 2011 |
Ariel HammermanHealth Technology Assessment Director, Medison Pharmaכתובת אימייל מאומתת בדומיין medisonpharma.com
